Shree Renuka Sugars (RENUKA) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
30 Oct, 2026Executive summary
Q2 FY27 consolidated revenue was INR 19,050 million and loss after tax was INR 1,939 million; the prior-year quarter recorded revenue of INR 24,890 million and loss after tax of INR 3,693 million.
H1 FY27 consolidated revenue was INR 40,252 million, with loss before tax of INR 5,178 million and loss attributable to parent shareholders of INR 3,686 million.
Financial highlights
Q2 consolidated loss before tax narrowed to INR 2,019 million from INR 4,013 million YoY; H1 loss before tax narrowed to INR 5,178 million from INR 7,427 million.
Q2 consolidated EPS was -INR 0.91 versus -INR 1.73 YoY; H1 EPS was -INR 2.09 versus -INR 2.97.
Consolidated H1 operating cash flow was INR 6,942 million, up from INR 1,757 million; cash and cash equivalents ended the period at INR 666 million.
Outlook and guidance
Management expects financial obligations to be met on time, supported by a holding-company letter of support for working capital needs and guarantees for long-term loans, ECBs and NCDs.
Latest events from Shree Renuka Sugars
- Strong FY05 growth and an oversubscribed IPO set up a major capacity expansion.RENUKA
Q4 04/05 - Revenue rose 39%, PAT more than doubled, and expansion accelerated amid export constraints.RENUKA
Q4 05/06 - Record earnings amid a sugar slump, powered by exports and integrated co-products.RENUKA
Q4 02/03 - Ethanol gains lifted profit as exports fell and sugar capacity expanded.RENUKA
Q4 03/04 - Revenue grew 120% as renewables drove profits and expansion continued.RENUKA
Q4 07/08 - Sugar glut pressured FY07 earnings as ethanol capacity expansion became a key growth bet.RENUKA
Q4 06/07 - Strong FY09 growth met a strategic push into refining and Brazilian feedstock.RENUKA
Q4 08/09 - Record growth and Brazilian expansion lifted scale, alongside higher leverage and commodity exposure.RENUKA
Q4 09/10 - FX losses and weak sugar economics drove deep losses; Wilmar equity aimed to ease debt.RENUKA
Q4 13/14